Carmen C. Deseda

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
To prepare for a Phase III dengue vaccine efficacy trial, 20 investigational sites were selected for this observational study to identify dengue infections in a closed cohort (N = 3,000 children 9-16 years of age). Of 255 acute febrile episodes experienced by 235 children, 50 (21.3%) were considered serologically probable dengue, and 18 (7.7%) were(More)
  • 1